AAAAAA

   
Results: 1-9 |
Results: 9
Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists
Authors: DiPardo, RM Patane, MA Newton, RC Price, RA Broten, TP Chang, RSL Ransom, RW Di Salvo, J Freidinger, RM Bock, MG
Citation: Rm. Dipardo et al., Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists, BIOORG MED, 11(14), 2001, pp. 1959-1962
Phenylacetamides as selective alpha-1A adrenergic receptor antagonists
Authors: Patane, MA DiPardo, RM Newton, RC Price, RP Broten, TP Chang, RSL Ransom, RW Di Salvo, J Nagarathnam, D Forray, C Gluchowski, C Bock, MG
Citation: Ma. Patane et al., Phenylacetamides as selective alpha-1A adrenergic receptor antagonists, BIOORG MED, 10(15), 2000, pp. 1621-1624
Selective alpha(1a) adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones
Authors: Nantermet, PG Barrow, JC Selnick, HG Homnick, CF Freidinger, RM Chang, RSL O'Malley, SS Reiss, DR Broten, TP Ransom, RW Pettibone, DJ Olah, T Forray, C
Citation: Pg. Nantermet et al., Selective alpha(1a) adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones, BIOORG MED, 10(15), 2000, pp. 1625-1628
De novo design of a novel oxazolidinone analogue as a potent and selectivealpha(1A) adrenergic receptor antagonist with high oral bioavailability
Authors: Lagu, B Tian, D Jeon, Y Li, C Wetzel, JM Nagarathnam, D Shen, QR Forray, C Chang, RSL Broten, TP Ransom, RW Chan, TB O'Malley, SS Schorn, TW Rodrigues, AD Kassahun, K Pettibone, DJ Freidinger, R Gluchowski, C
Citation: B. Lagu et al., De novo design of a novel oxazolidinone analogue as a potent and selectivealpha(1A) adrenergic receptor antagonist with high oral bioavailability, J MED CHEM, 43(15), 2000, pp. 2775-2778
In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia
Authors: Barrow, JC Nantermet, PG Selnick, HG Glass, KL Rittle, KE Gilbert, KF Steele, TG Homnick, CF Freidinger, RM Ransom, RW Kling, P Reiss, D Broten, TP Schorn, TW Chang, RSL O'Malley, SS Olah, TV Ellis, JD Barrish, A Kassahun, K Leppert, P Nagarathnam, D Forray, C
Citation: Jc. Barrow et al., In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia, J MED CHEM, 43(14), 2000, pp. 2703-2718
4-Oxospiro[benzopyran-2,4 '-piperidines] as selective alpha(1a)-adrenergicreceptor antagonists
Authors: Nerenberg, JB Erb, JM Bergman, JM O'Malley, S Chang, RSL Scott, AL Broten, TP Bock, MG
Citation: Jb. Nerenberg et al., 4-Oxospiro[benzopyran-2,4 '-piperidines] as selective alpha(1a)-adrenergicreceptor antagonists, BIOORG MED, 9(2), 1999, pp. 291-294
Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones
Authors: Nagarathnam, D Miao, SW Lagu, B Chiu, G Fang, J Dhar, TGM Zhang, J Tyagarajan, S Marzabadi, MR Zhang, FQ Wong, WC Sun, WY Tian, D Wetzel, JM Forray, C Chang, RSL Broten, TP Ransom, RW Schorn, TW Chen, TB O'Malley, S Kling, P Schneck, K Bendesky, R Harrell, CM Vyas, KP Gluchowski, C
Citation: D. Nagarathnam et al., Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones, J MED CHEM, 42(23), 1999, pp. 4764-4777
Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification oflinker and 4-methoxycarbonyl-4-phenylpiperidine moiety
Authors: Dhar, TGM Nagarathnam, D Marzabadi, MR Lagu, B Wong, WC Chiu, G Tyagarajan, S Miao, SW Zhang, FQ Sun, WY Tian, D Shen, QR Zhang, J Wetzel, JM Forray, C Chang, RSL Broten, TP Schorn, TW Chen, TB O'Malley, S Ransom, R Schneck, K Bendesky, R Harrell, CM Vyas, KP Zhang, KY Gilbert, J Pettibone, DJ Patane, MA Bock, MG Freidinger, RM Gluchowski, C
Citation: Tgm. Dhar et al., Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification oflinker and 4-methoxycarbonyl-4-phenylpiperidine moiety, J MED CHEM, 42(23), 1999, pp. 4778-4793
Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series
Authors: Wong, WC Sun, WY Lagu, B Tian, D Marzabadi, MR Zhang, FQ Nagarathnam, D Miao, SW Wetzel, JM Peng, J Forray, C Chang, RSL Chen, TB Ransom, R O'Malley, S Broten, TP Kling, P Vyas, KP Zhang, KY Gluchowski, C
Citation: Wc. Wong et al., Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series, J MED CHEM, 42(23), 1999, pp. 4804-4813
Risultati: 1-9 |